Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: UMLS:C0022116 (
ischemia
)
91,303
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
Melatonin is synthesized from serotonin by the action of
arylalkylamine N-acetyltransferase
(
AANAT
) and hydroxyindole-O-methyltransferase. In this study, we observed cellular changes of
arylalkylamine N-acetyltransferase
(
EC 2.3.1.87
;
AANAT
) in the hippocampal CA1 region at various time points after
ischemia
/reperfusion. In vehicle-treated sham group,
AANAT
immunoreaction was detected in pyramidal neurons of the CA1 region.
AANAT
immunoreactivity in the neurons was highest 2 days and disappeared from 4 days after
ischemia
/reperfusion. From 3 days after
ischemia
/reperfusion,
AANAT
immunoreaction was expressed in astrocytes in the strata oriens and radiatum of the CA1 region. AANAT protein and mRNA levels were significantly increased 2 days after
ischemia
/reperfusion, and markedly decreased from 5 days after
ischemia
/reperfusion. The repeated administration of melatonin (10 mg/kg, i.p.) 3 times (once a day) to gerbils before
ischemia
/reperfusion significantly reduced
ischemia
-induced hyperactivity as well as neuronal death compared to those in the vehicle-treated
ischemia
group. Melatonin treatment also maintained
AANAT
immunoreactivity and its protein levels in the CA1 region after
ischemia
/reperfusion. These results suggest that the reduction of
AANAT
in ischemic CA1 region is associated with delayed neuronal death following transient
ischemia
, and melatonin treatment shows neuroprotection with maintenance of
AANAT
levels in the ischemic CA1 region.
...
PMID:Arylalkylamine N-acetyltransferase (AANAT) is expressed in astrocytes and melatonin treatment maintains AANAT in the gerbil hippocampus induced by transient cerebral ischemia. 2048 63